LG 101506: High-Purity RXR Modulator for Advanced Nuclear Receptor Research

Executive Summary: LG 101506 is a small molecule Retinoid X Receptor (RXR) modulator with 98% purity and a molecular weight of 420.53, designed for scientific research use only (APExBIO). It offers solubility of up to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol under standard laboratory conditions. LG 101506 is stable when stored at -20°C and is provided as an off-white solid. The compound is specifically intended for studying RXR signaling, with implications for metabolism regulation and nuclear receptor-related disease models (Zhang et al. 2022). This product is not for diagnostic or medical applications.

Biological Rationale

Retinoid X Receptors (RXRs) are nuclear receptors that form heterodimers with other nuclear receptors, modulating gene expression across diverse physiological processes, including metabolism, cell proliferation, and immune regulation (Zhang et al. 2022). RXR signaling is implicated in metabolic homeostasis and is a key node in nuclear receptor crosstalk. Modulation of RXR activity is relevant for dissecting the mechanisms underlying diseases such as cancer, metabolic syndrome, and immune-related disorders. The precise manipulation of RXR via small molecule modulators like LG 101506 enables controlled experimental interrogation of these pathways. RXR’s role in immune checkpoint regulation, particularly in the context of PD-L1 expression and T-cell-mediated anti-tumor immunity, has received growing attention (LG 101506: RXR Modulation and Immune Checkpoint Regulation). This article extends prior reviews by integrating recent mechanistic data linking RXR modulation to immune checkpoint biology.

Mechanism of Action of LG 101506

LG 101506 is chemically defined as (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid. It acts as a modulator of RXR by binding to its ligand-binding domain, thereby influencing the heterodimerization and transcriptional activity of RXR and its partners. By altering RXR activity, LG 101506 impacts downstream transcriptional programs involved in lipid metabolism, glucose regulation, and immune cell differentiation (LG 101506: High-Purity RXR Modulator for Advanced Nuclear...). Unlike broad-spectrum nuclear receptor ligands, LG 101506 exhibits specificity for RXR, reducing off-target effects on other nuclear receptor subfamilies. This article clarifies the precise molecular action of LG 101506 compared to previous overviews, focusing on its utility in dissecting RXR-dependent pathways.

Evidence & Benchmarks

• LG 101506 demonstrates solubility up to 42.05 mg/ml in DMSO and 21.03 mg/ml in ethanol at 20°C, enabling high-concentration dosing in cell-based assays (APExBIO).
• The compound exhibits a molecular weight of 420.53 and is supplied at ≥98% purity, verified by HPLC and NMR analysis (APExBIO).
• RXR signaling is mechanistically linked to immune checkpoint regulation, with nuclear receptor modulation shown to impact PD-L1 stability and glycosylation in cancer models (Zhang et al. 2022).
• Loss of RBMS1, a regulator of PD-L1 mRNA stability, enhances anti-tumor immunity by promoting PD-L1 degradation, a process influenced by nuclear receptor signaling, including RXR pathways (Zhang et al. 2022).
• LG 101506 provides a chemically stable, reproducible standard for RXR pathway studies, outperforming earlier RXR ligands in purity and defined solubility (LG 101506: Next-Generation RXR Modulator for Nuclear Rece...).

Common Pitfalls or Misconceptions

• LG 101506 is not intended for in vivo diagnostic or therapeutic use; it is strictly for laboratory research (APExBIO).
• Long-term storage of LG 101506 solutions decreases stability; researchers should prepare fresh solutions and use them promptly.
• The compound's activity is specific to RXR and may not generalize to other nuclear receptor families.
• Solubility may differ in non-standard solvents or at temperatures above 20°C.
• Interpretation of PD-L1 modulation should consider cell context, as RXR signaling effects can be cell-type dependent (Zhang et al. 2022).

Applications, Limits & Misconceptions

LG 101506 is a preferred tool for studies investigating RXR signaling in metabolism, immune regulation, and cancer biology. It is particularly suited for experiments dissecting the RXR-dependent regulation of PD-L1 expression and immune checkpoint engagement. The compound’s high purity and defined solubility support quantitative dose-response and mechanistic studies in cell culture and biochemical assays.

However, LG 101506 is not validated for in vivo clinical or diagnostic applications. Its effects are limited to RXR-mediated pathways, and it should not be assumed to modulate other nuclear receptor classes. Misinterpretation may arise if experimental design does not consider specificity and correct storage conditions. For a deeper discussion of LG 101506 in cancer immunology and immunometabolic research, see LG 101506: Unraveling RXR Modulation in Cancer Immunity R..., which this article updates by providing new data on solubility and purity standards.

Workflow Integration & Parameters

To maximize reproducibility, LG 101506 should be stored as a solid at -20°C, protected from moisture and light. Solutions in DMSO or ethanol should be freshly prepared at concentrations up to 42.05 mg/ml and 21.03 mg/ml respectively, and used promptly. For cell-based assays, typical working concentrations range from 0.1–10 μM, but optimal dosing may require empirical titration depending on cell type and endpoint (APExBIO).

Shipping is performed on blue ice for small molecule form or on dry ice for modified nucleotides, ensuring stability during transit. Use of LG 101506 in RXR signaling pathway research often involves co-treatment with other nuclear receptor ligands or pathway inhibitors to dissect crosstalk effects. For a robust workflow, consult the detailed product documentation available at the LG 101506 product page. For comparative workflow strategies, see LG 101506: Unlocking RXR Modulation for Immunometabolic a..., which focuses on immunometabolic integration, while this review emphasizes nuclear receptor and checkpoint specificity.

Conclusion & Outlook

LG 101506, provided by APExBIO, establishes a new benchmark for RXR modulator quality, supporting advanced research into nuclear receptor signaling, metabolism, and immune checkpoint regulation. Its defined chemical properties, stability, and specificity enable reproducible, mechanistic studies central to understanding RXR function in health and disease. Ongoing research is expected to further elucidate RXR’s role in immune modulation and metabolic reprogramming, with LG 101506 serving as a foundational tool for these investigations (Zhang et al. 2022).